This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300 mg dosage medication. The contract, valued at $15,219.50, is a Firm Fixed Price Delivery Order with an ultimate completion date of October 7, 2024. Amerisourcebergen, through its Corporate Office division, will provide the medication to support federal healthcare programs and services, particularly for military treatment facilities and veterans' hospitals. This contract is not designated as a set-aside and is part of Amerisourcebergen's broader federal contracting activities, which include Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation for a wide range of pharmaceutical and medical supplies.
Generated 1/3/25, 9:23 AM